Description
NEXPLANON IMPLANTS FOR NAVAL RECRUITS AT FHCC
First action · last action
2013-10-22 · 2013-10-22
Transactions
1
First transaction's obligation
$149,797
Base + all options value (sum of deltas)
$149,797
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D30047
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-10-22+$149,797= $149,797
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-10-22 | +$149,797 | $149,797 | NEXPLANON IMPLANTS FOR NAVAL RECRUITS AT FHCC |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FCFDA78HKKG2)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24526N0671 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,508 | FY2026 |
| 36C24526N0647 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,508 | FY2026 |
| 36C24526N0664 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,508 | FY2026 |
| 36C24526N0596 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,508 | FY2026 |
| 36C24526N0578 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $22,508 | FY2026 |
| 36C26026F0282 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $342,254 | FY2026 |
Other recipients under 6505 from 69D-NETWORK CONTRACT OFFICE 12 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA69D16F2903 | CSL BEHRING L.L.C. | 69D-NETWORK CONTRACT OFFICE 12 | $5,443 | FY2016 |
| VA69D16F2824 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $53,837 | FY2016 |
| VA69D16F2687 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $54,563 | FY2016 |
| VA69D16F2660 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $125,000 | FY2016 |
| VA69D16F2665 | GRIFOLS THERAPEUTICS LLC | 69D-NETWORK CONTRACT OFFICE 12 | $5,386 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69D14F0004_3600_V797D30047_3600 · retrieved 2026-09-26.